US buyout Funds are Paying More for Less (Preqin)
As competition in the US buyout market intensifies, funds are paying a whole lot more for deals. That’s true not just in absolute terms, but in relative terms as well. Let’s start with absolute numbers. At the end of 2020, the average deal value for a US-based asset was $1.05bn, which is an annual increase of 10% on average since 2011. But 2021 saw a much sharper rise when the average deal value spiked by $307mn, or 29.4%. Not only are fund managers faced with higher prices – they’re also paying more for less.
Speculative Hedge Fund Trades Behind Won’s Drop, Say Forex Dealers (Hedge Week)
Bets by a number of global hedge funds on further falls in the value of the won are behind the South Korean currency’s continuing fall in value, according to a report by Korea Economic Daily. The report cites foreign exchange dealers as claiming that a continued decline in the value of the currency, which recently hit a 13-and-a-half year low is attributable to bets by multiple global funds, including the the world’s largest hedge fund Bridgewater Associates. The funds have reportedly sold the won in offshore non-deliverable forward (NDF) markets, in which they would buy it back in the coming months at pre-agreed rates.
Thursday 9/15 Insider Buying Report: VVX, SRPT (Nasdaq.om)
On Wednesday, V2X’s, Dino M. Cusumano, made a $15.00M purchase of VVX, buying 375,420 shares at a cost of $39.96 a piece. So far Cusumano is in the green, up about 4.5% on their purchase based on today’s trading high of $41.74. V2X is trading up about 3% on the day Thursday. And at Sarepta Therapeutics, there was insider buying on Wednesday, by Director Michael Andrew Chambers who purchased 57,100 shares at a cost of $104.43 each, for a trade totaling $5.96M. Before this latest buy, Chambers made one other purchase in the past twelve months, buying $5M shares for a cost of $108.28 each. Sarepta Therapeutics is trading off about 0.1% on the day Thursday. Chambers was up about 4.0% on the purchase at the high point of today’s trading session, with SRPT trading as high as $108.56 at last check today.
Tesla, Dell And 1 Other Technology Stock Insiders Are Selling (Benzinga)
Tesla: The Trade: Tesla, Inc. (TSLA) Chief Financial Officer Zachary Kirkhorn sold a total of 3,750 shares at an average price of $300.59. The insider received around $1.13 million from selling those shares. Dell Technologies: The Trade: Dell Technologies Inc. (DELL) Pres., Glob. Sales & Cust. Ops William Scannell sold a total of 27,536 shares at an average price of $40.20. The insider received around $1.11 million from selling those shares.
10 Blue Chip Stocks to Buy According to Billionaire Jim Simons (Insider Monkey)
In this article, we discuss 10 blue chip stocks to buy according to billionaire Jim Simons. You can skip our detailed analysis of Renaissance Technologies’ strategy and the current market outlook and go directly to 5 Blue Chip Stocks to Buy According to Billionaire Jim Simons. Jim Simons is a leading mathematician and investor who this year appeared on the Forbes list of U.S. billionaires, ranking 48th, with a net worth of $29 billion. He is the founder of Renaissance Technologies, a Setauket, New York-based hedge fund that manages. Its signature Medallion fund has delivered average annual returns of about 40% since 1988 and has paid him about $12 billion in cash distributions since 2006.
